We need a common language, say researchers
Thursday 18 August 2011
This month's EJC News Focus looks at the assessment of toxicities in Phase 1 trials of molecular treatments for cancer. Jean-Charles Soria explains that the principles underlying this area of research are up to 50 years old. He makes the case for a consensus and a "common language" for describing and assessing toxicities.
>> http://www.orlandomedia.co.uk/clients/ejc/ejcnf08.php
European Oncology Nursing SocietyAvenue E. Mounier 83
B-1200 Brussels
Belgium
Tel: +32 (0)2 779 9923
Fax: +32 (0)2 779 9937
eons.secretariat@cancernurse.eu